The Lorazepam 0.33 mg/Diphenhydramine HCl 12.5 mg/Haloperidol 2 mg Suppository is a compounded formulation designed to address a range of health conditions. This unique combination of active ingredients includes Lorazepam, a benzodiazepine used for the management of anxiety disorders, insomnia, and seizures; Diphenhydramine HCl, an antihistamine that provides relief from allergies, cold symptoms, and insomnia; and Haloperidol, an antipsychotic medication used in the treatment of conditions such as schizophrenia, bipolar disorder, and Tourette's syndrome.

This medication is presented in the form of a suppository, a solid dosage form that is inserted into a body cavity, typically the rectum or vagina. The suppository dissolves or melts once inserted, releasing the medication for local or systemic absorption. This method of administration allows for the medication to be absorbed directly into the bloodstream, bypassing the digestive system and potentially offering a faster onset of action.

Each suppository is carefully compounded by our skilled pharmacists at Bayview Pharmacy. Compounding allows for personalized medication solutions, catering to the specific needs and preferences of each individual patient. This can include adjusting the strength of a medication, combining multiple medications into a single dosage form, or creating a medication in a form that is not commercially available.

If you have any questions or concerns about this compounded formulation, or if you would like to discuss how it could be tailored to your specific treatment needs, please do not hesitate to contact us. Our team is committed to providing comprehensive, patient-centered care and is always available to assist you.

This compounded formulation of Lorazepam 0.33 mg, Diphenhydramine HCl 12.5 mg, and Haloperidol 2 mg is a suppository, a solid dosage form that is inserted into a body cavity, typically the rectum or vagina. It dissolves or melts to release medication for local or systemic absorption.

Interactions: The active ingredients in this formulation, Lorazepam, Diphenhydramine HCl, and Haloperidol, may interact with other medications, including prescription and over-the-counter drugs, vitamins, and herbal supplements. It is crucial to inform your doctor and pharmacist about all the products you use, including prescription drugs, non-prescription drugs, and herbal products.

Lorazepam may interact with medications that cause drowsiness, such as antihistamines, muscle relaxants, narcotic pain relievers, sleeping pills, and tranquilizers. It may also interact with medications that affect the central nervous system, such as antidepressants, anti-seizure medications, and antipsychotics.

Diphenhydramine HCl may interact with medications that cause drowsiness, such as antihistamines, muscle relaxants, narcotic pain relievers, sleeping pills, and tranquilizers. It may also interact with medications that affect the central nervous system, such as antidepressants, anti-seizure medications, and antipsychotics.

Haloperidol may interact with medications that affect the central nervous system, such as antidepressants, anti-seizure medications, and antipsychotics. It may also interact with medications that cause drowsiness, such as antihistamines, muscle relaxants, narcotic pain relievers, sleeping pills, and tranquilizers.

This formulation is used to treat a variety of disease states, including anxiety, insomnia, and psychosis. It is important to inform your doctor and pharmacist about all the products you use, including prescription drugs, non-prescription drugs, and herbal products.

If you have any questions about the interactions of this formulation, please reach out to your healthcare provider or pharmacist.

This compounded formulation of Lorazepam 0.33 mg/Diphenhydramine HCl 12.5 mg/Haloperidol 2 mg Suppository is designed to treat a range of conditions by leveraging the combined effects of its three active ingredients. Lorazepam, a benzodiazepine, works to alleviate anxiety and agitation. Diphenhydramine HCl, an antihistamine, aids in reducing itching and inflammation. Haloperidol, an antipsychotic, assists in mitigating psychotic symptoms.

When using this formulation, it is crucial to adhere to the instructions provided by your healthcare professional. The suppository should be inserted into the rectum as directed. It is essential to use the correct dosage and not to exceed the recommended dose. Furthermore, this formulation should not be used for a longer duration than advised.

This formulation may lead to side effects such as drowsiness, dizziness, dry mouth, and constipation. If you experience any of these side effects, it is important to immediately contact your healthcare provider. Additionally, it is vital to inform your healthcare provider if you are taking any other medications, as they may interact with this formulation.

If you have any queries about this formulation or its mechanism of action, do not hesitate to ask. We are here to assist you in finding the most effective treatment for your condition.

This compounded formulation of Lorazepam 0.33 mg/Diphenhydramine HCl 12.5 mg/Haloperidol 2 mg Suppository is a versatile medication with a wide range of potential uses. It may be employed in the treatment of various conditions such as nausea, vomiting, and motion sickness. This formulation is also beneficial in managing the symptoms of alcohol withdrawal, which can include tremors, agitation, and insomnia.

Furthermore, this suppository formulation can be used to alleviate the symptoms of opioid withdrawal, such as anxiety, agitation, and insomnia. It is also effective in reducing the symptoms associated with benzodiazepine withdrawal, including anxiety, agitation, and insomnia. This formulation can also be used to manage the symptoms of antipsychotic withdrawal, such as agitation, delirium, and insomnia.

Lastly, this formulation can be beneficial in managing the symptoms of sedative-hypnotic withdrawal, which can include anxiety, agitation, and insomnia. If you have any questions about the use of this formulation for any of these conditions, please do not hesitate to reach out for further information.